ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Children's Cancer Group


Include trials that are no longer recruiting patients.

26 studies were found.
1.No longer recruiting506U78 in Treating Patients With Refractory Hematologic Cancer
Conditions: recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
2.No longer recruitingChemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Conditions: stage II childhood Hodgkin's disease; stage III childhood Hodgkin's disease; cardiac toxicity; stage I childhood Hodgkin's disease; ...
3.No longer recruitingChemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: recurrent childhood acute myeloid leukemia; recurrent childhood acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia
4.No longer recruitingColony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Conditions: Brain Tumors; Musculoskeletal Tumors; Kidney Tumors; Solid Tumors
5.No longer recruitingCombination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
Conditions: stage III childhood Hodgkin's disease; stage IV childhood Hodgkin's disease; childhood lymphocyte predominant Hodgkin's disease; ...
6.No longer recruitingCombination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
Conditions: L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia
7.No longer recruitingCombination Chemotherapy in Treating Children With Lymphoma
Conditions: stage IV childhood large cell lymphoma; stage IV childhood lymphoblastic lymphoma
8.No longer recruitingCombination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: L1 childhood acute lymphocytic leukemia; L2 childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
9.No longer recruitingCombination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Conditions: Quality of Life; recurrent childhood acute lymphoblastic leukemia
10.No longer recruitingCombination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
Condition: unspecified childhood solid tumor, protocol specific
11.CompletedCombination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia; Previously Treated Myelodysplastic Syndrome
12.CompletedCombination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Conditions: metastatic tumors of the Ewing's family; Neutropenia
13.No longer recruitingCombination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
Conditions: cardiac toxicity; localized osteosarcoma
14.No longer recruitingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
Condition: disseminated neuroblastoma
15.No longer recruitingCombination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor
Conditions: untreated childhood supratentorial primitive neuroectodermal and pineal tumors; untreated childhood medulloblastoma
16.CompletedCombination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
Condition: untreated childhood acute lymphoblastic leukemia
17.No longer recruitingDetection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Previously Treated Myelodysplastic Syndrome; untreated childhood acute myeloid leukemia; secondary myelodysplastic syndrome; ...
18.No longer recruitingDiagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
Condition: recurrent childhood acute lymphoblastic leukemia
19.No longer recruitingDocetaxel in Treating Children With Recurrent Solid Tumors
Conditions: recurrent childhood brain stem glioma; recurrent childhood rhabdomyosarcoma; recurrent neuroblastoma; recurrent childhood ependymoma; ...
20.No longer recruitingFenretinide in Treating Children With Solid Tumors
Conditions: unspecified childhood solid tumor, protocol specific; recurrent neuroblastoma
21.CompletedGemcitabine in Treating Children With Refractory Solid Tumors
Condition: unspecified childhood solid tumor, protocol specific
22.CompletedHealth-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
Conditions: long-term effects secondary to cancer therapy in children; previously treated childhood rhabdomyosarcoma; Quality of Life
23.No longer recruitingQuality of Life in Children Treated for Cancer
Conditions: Leukemia; Lymphoma
24.No longer recruitingRadiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Condition: untreated childhood medulloblastoma
25.No longer recruitingRadiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors
Conditions: disseminated neuroblastoma; untreated childhood supratentorial primitive neuroectodermal and pineal tumors; regional neuroblastoma; ...
26.CompletedVinblastine and Methotrexate in Treating Children With Desmoid Tumors
Condition: desmoid tumor

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act